Key Takeaways CLX is expected to post Q4 revenue of $1.94B and EPS of$2.25, up 2% and 23.6% year over year.Clorox's IGNITE strategy and premium launches like Scentiva support growth despite a tough consumer landscape.Gross margin is projected to be 44% in Q4, aided by cost discipline and retailer inventory builds.The Clorox Company (CLX) is slated to report fiscal fourth-quarter 2025 earnings on July 31, after market close. The company is expected to register year-over-year top-and-bottom-line growth when ...